Joel M Topf MD

PubMed

• Things We Do for No Reason™: Avoiding intravenous iodinated contrast material in patients with acute kidney injury or chronic kidney disease.
  Caroline Coleman, Meredith Trubitt, Joel Topf, Monee Amin
  Journal of Hospital Medicine. 2025-04-21
• Protein restriction in CKD: an outdated strategy in the modern era.
  Abdullah Bawazir, Joel M Topf, Swapnil Hiremath
  Jornal Brasileiro De Nefrologia. 2025-02-11
• Renal Physiology Education via Podcast: Channel Your Enthusiasm.
  Melanie P Hoenig, Anna R Gaddy, Priti Meena, Roger A Rodby, Leticia Rolón
  Kidney Medicine. 2024-11-01

Journal Articles

• Social media, medicine and the modern journal club  
  Topf J, Hiremath S, Int Rev Psychiatry, 1/1/2015
• Ten Steps for Setting Up an Online Journal Club  
  Chan TM, Thoma B, Radecki R, Topf J, Woo HH, Kao LS, Cochran A, Hiremath S, Lin M, J Contin Educ Health Prof, 1/1/2015
• NephMadness 2015: Nephrology as a Cornerstone of Medicine  
  Sparks MA, Lerma EV, Kupin W, Phelan PJ, Jhaveri KD, Topf J, Am J Kidney Dis, 1/1/2015
• The state of the blog: the first year of eAJKD  
  Desai T, Sparks MA, Nair V, Sethi SK, Topf J, Calderon K, Bury E, Jhaveri KD, Am J Kidney Dis, 1/1/2013
• Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis  
  EVOLVE Trial Investigators, Chertow GM, et al, N Engl J Med, 1/1/2012
• CERA: third generation erythropoiesis-stimulating agent  
  Topf JM, Expert Opin. Pharmacother, 1/1/2008
• Nephrogenic fibrosing dermopathy  
  Dungal A, Lattupalli R, Topf J, The Scientific World Journal, 1/1/2008
• Prevalence of proteinuria and the development of chronic kidney disease in HIV infected patients  
  Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP, Clin Nephrol, 1/1/2004
• Prevalence of proteinuria and the development of chronic kidney disease in HIV infected patients.  
  Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP, Clin Nephrol; 61: 1-6
• Join now to see all

Books/Book Chapters

• Chronic Kidney Disease and Hypertension 
  Chapter: Blood Pressure Vaccines 
  Page 91.0 - 100.0Phisitkul S, Topf, JMEditors: M. Weir, E. Lerma.Humana Press, New York, NY2015
• Michigan Hypertension Core Curriculum 
  Chapter: Lifestyle Modifications 
  Topf JMNational Kidney Foundation of Michigan and Michigan Department of Community Health2010
• Intensive Care Nephrology 
  Chapter: Disorders of potassium homeostasis 
  Page 363.0 - 382.0Topf JM, Asplin JREditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom2006
• Intensive Care Nephrology 
  Chapter: Disorders of calcium, phosphorous, and magnesium 
  Page 383.0 - 412.0Topf JM, Worcester EEditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom2006
• Principles of Critical Care 
  Chapter: Electrolyte disorders in critical care 
  Page 1117. - 1133.Topf JM, Rankin S, Murray PTEditors: Hall JB, Schmidt GA, Wood LDH.McGraw-Hill Professional, United States2005
• The Fluid, Electrolyte and Acid-Base Companion 
  Faubel S, Topf JMAlert and Oriented Publishing, La Jolla, California1999
• The Microbiology Companion 
  Topf JM, Faubel SAlert and Oriented Publishing, La Jolla, CaliforniaEdition 2nd,1998
• The Microbiology Companion 
  Topf JM, Faubel SAlert and Oriented Publishing, Ann Arbor, MichiganEdition 2nd,1994
• The Microbiology Companion 
  Topf JM, Faubel SAlert and Oriented Publishing, Ann Arbor, Michigan1993
• The Fluid, Electrolyte and Acid-Base Companion. 
  Faubel S, Topf JMAlert and Oriented Publishing, La Jolla California
• The Microbiology Companion. 
  Topf JM, Faubel SAlert and Oriented Publishing, La Jolla CaliforniaEdition 2nd,
• Intensive Care Nephrology. 
  Chapter: Disorders of potassium homeostasis 
  Page 363 - 382Topf JM, Asplin JREditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom
• Intensive Care Nephrology. 
  Chapter: Disorders of calcium, phosphorous, and magnesium 
  Page 383 - 412Topf JM, Worcester EEditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom
• Principles of Critical Care. 
  Chapter: Electrolyte disorders in critical care 
  Page 1117 - 1133Topf JM, Rankin S, Murray PTEditors: Hall JB, Schmidt GA, Wood LDH.McGraw-Hill Professional, United States
• Join now to see all

Abstracts/Posters

• NephMadness 2014, a Social Media Campaign to Promote Nephrology Education and Interest
  Topf J, Sparks MA, Lerma EV, Kupin WL, Jhaveri KD, ASN Kidney Week, 1/1/2014
• Correction Rate of Severe Hypernatremia and Morbidity and Mortality in Hospitalized Patients
  Abdulrazzak A, El-Kateb M, Melidonian M, Henderson HL, Topf J, ASN Kidney Week, 1/1/2014
• Key Characteristics of Current Social Media Policies at U.S. Allopathic Medical Schools
  Xi A, Topf J, Med 2.0’13 Conference, London, England, 1/1/2013
• Nephrology Blogosphere: An Analysis of Productivity, Longevity, and Consistency
  Topf JM, ASN Kidney Week, 1/1/2013
• The Utility of Fractional Excretion of Sodium and Urea in Advanced Chronic Kidney Disease
  Noureldeen T, Topf JM, ASN Renal Week, 1/1/2011
• Resistant Hypertension: A CKD Clinic Intervention Program To Improve Patient Care
  Pandey AK, Steigerwalt SP, Szpunar SM, Topf JM, Bellovich KA, Provenzano R, ASN Kidney Week, 1/1/2010
• Predictors of Outcome in the Elderly Patients with Chronic Kidney Disease (CKD)
  Marin M, Ishaq RT, Diaz AB Topf JM, ASN Kidney Week, 1/1/2010
• First Year Dialysis Mortality in Patients Previously Enrolled in a Structured Chronic Kidney Disease (CKD) Program
  Topf JM, Provenzano R, Wilson R, Choksi AJ, Bogan A, Amer J Kidney Dis, 1/1/2009
• Nephrogenic Fibrosing Dermopathy (NFD) in a Patient with Acute Kidney Injury (AKI)
  Dhungel A, Lattupalli R, El Ghoroury M, Provenzano R, Topf JM, Amer J Kidney Dis, 1/1/2008
• Predictors of Progressive Versus Stable Chronic Kidney Disease
  Abud G, Topf JM, Provenzano R, J Amer Soc Nephrol, 1/1/2008
• Nephrogenic Fibrosing Dermopathy (NFD): Case Series of 3 Patients in a Single Center
  Lattupalli R, Dhungel A, Bellovich K, Provenzano R, Topf JM, Amer J Kidney Dis, 1/1/2008
• Steroid Resistant Minimal Change Disease Associated With Thymoma: A Case Report
  Lattupalli R, Khairullah Q, Bellovich K, Topf JM, Amer J Kidney Dis, 1/1/2008
• CKD (chronic kidney disease) clinics improve anemia, lipids and arrest the decline of GFR
  Topf JM, Abud G, Provenzano R, J Amer Soc Nephrol, 1/1/2006
• Use of aldosterone antagonists (AA) are associated with achieved blood pressure (BP) control in chronic kidney disease (CKD)
  Topf JM, Steigerwalt S, Provenzano R, J Amer Soc Nephrol, 1/1/2006
• Hyperkalemia in a chronic kidney disease clinic: frequency, risk factors and protective agents
  Topf JM, Alumit G, J Amer Soc Nephrol, 1/1/2006
• Aldosterone antagonists (AA) are associated with achieved target blood pressure in chronic kidney disease (CKD)
  Topf JM, Steigerwalt S, Provenzano R, American Society of Hypertension, New York, NY, 1/1/2006
• The Prevalence of Antiphospholipid Antibodies (APA) in LATE Chronic Kidney Disease (CKD) and incidence following initiation of dialysis
  Topf JM, Shahab H, Mantena S, Nagrecha N, J Amer Soc Nephrol, 1/1/2006
• Cyanide toxicity from nitroprusside in a patient with chronic kidney disease
  Venugopal A, Topf JM, Amer J Kidney Dis, 1/1/2006
• Blood pressure (BP) control by race, gender and chronic kidney disease (CKD) stage in a CKD clinic
  Topf JM, Steigerwalt S, Provenzano R, Amer J Kidney Dis, 1/1/2006
• Lactic acidosis cannot be used to explain an osmolal gap in patients with potential ethylene glycol toxicity. A case report and review of the literature
  Topf JM, Jayakar S, Amer J Kidney Dis, 1/1/2006
• Minimal change disease with incidental mesangial IgA deposits preceding Hodgkin’s lymphoma
  Jefic D, Topf JM, Amer J Kidney Dis, 1/1/2006
• Anemia Outcomes from a Medical-Assistant Driven Anemia Protocol To Treat Patients and Move Toward Monthly Epoetin Dosing
  Topf JM, Rehman I, Abud, G Maria V, Provenzano R, J Amer Soc Nephrol, 1/1/2005
• The Prevalence of Antiphospholipid Antibodies (APL) in Chronic Kidney Disease (CKD)
  Nagrecha N, Mantena S, Topf JM, J Amer Soc Nephrol, 1/1/2005
• The Prevalence of Antiphospholipid Antibodies (APL) in Chronic Kidney Disease (CKD).
  Nagrecha N, Mantena S, Topf JM, J Amer Soc Nephrol; 16: 521A
• Minimal change disease with incidental mesangial IgA deposits preceding Hodgkin’s lymphoma.
  Jefic D, Topf JM, J Kidney Dis, 47(4); A6
• Join now to see all

Lectures

• How to Dip Your Toes into Social Media 
  Montreal, Canada - 1/1/2015
• A Nephrologists guide to getting started in social media 
  Philadelphia, PA - 1/1/2014
• NephMadness: Social Media Campaign to Promote Nephrology Education and Interest 
  Atlanta, GA - 1/1/2013
• Uric Acid and the connection to hypertension and CKD 
  1/1/2013
• Prescribe an App 
  London, England - 1/1/2013
• What is Excellent Supportive Care in Patients with Acute Kidney Injury? How Can I do a Radiologic Study Without Harming My Patient 
  Denver, CO - 1/1/2010
• Use of Handheld Computers in Pediatrics 
  Chicago, IL - 1/1/2004
• Join now to see all

Other

• Acute Renal Failure: Finally, Some Progress 
  Topf JM, Renal & Urology News
  1/1/2006
• Autosomal recessive polycystic kidney disease 
  Topf JM
  UPCMD.com
  1/1/2000
• Autosomal dominant polycystic kidney disease 
  Topf JM
  UPCMD.com
  1/1/2000
• iOS application for pediatricians. Interactive database of age-based normals. 
  Topf JM, Mamlin BW
  http://www.kidometer.com
• Join now to see all